Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors.
Front Immunol. 2022 Jul 7;13:903591. doi: 10.3389/fimmu.2022.903591. eCollection 2022.
Front Immunol. 2022.
PMID: 35874722
Free PMC article.